Cargando…
BCX4430 – A broad-spectrum antiviral adenosine nucleoside analog under development for the treatment of Ebola virus disease
The adenosine nucleoside analog BCX4430 is a direct-acting antiviral drug under investigation for the treatment of serious and life-threatening infections from highly pathogenic viruses, such as the Ebola virus. Cellular kinases phosphorylate BCX4430 to a triphosphate that mimics ATP; viral RNA poly...
Autores principales: | Taylor, Raymond, Kotian, Pravin, Warren, Travis, Panchal, Rekha, Bavari, Sina, Julander, Justin, Dobo, Sylvia, Rose, Angela, El-Kattan, Yahya, Taubenheim, Brian, Babu, Yarlagadda, Sheridan, William P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
King Saud Bin Abdulaziz University for Health Sciences. Production and hosting by Elsevier Limited.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937725/ https://www.ncbi.nlm.nih.gov/pubmed/27095300 http://dx.doi.org/10.1016/j.jiph.2016.04.002 |
Ejemplares similares
-
Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430
por: Warren, Travis K., et al.
Publicado: (2014) -
An update on the progress of galidesivir (BCX4430), a broad-spectrum antiviral
por: Julander, Justin G., et al.
Publicado: (2021) -
Model-independent confirmation of the $Z(4430)^-$ state
por: Aaij, Roel, et al.
Publicado: (2015) -
Confirmation of the exotic $Z(4430)^±$ resonance at LHCb
por: Cowan, Greig
Publicado: (2014) -
Observation of the resonant character of the $Z(4430)^-$ state
por: Aaij, Roel, et al.
Publicado: (2014)